Analysts of Ipopema Securities in a report dated July 6th, 2017 upgraded their recommendation for AmRest to "buy" from "sell" and raised the target price to PLN 400 per share from PLN 200.
You can place three widgets here, from which you plan to use most often.Next tip
Here you can put up three more widgets.Next tip
Drag the widget you are interested to one of the previously mentioned areas (under the side menu or at the bottom of the site).
We wish you a pleasant use of the site!Close tips